Vital exhaustion, anger expression, and pituitary and adrenocortical hormones: Implications for the insulin resistance syndrome

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 2, 1996, Pages 275-280

  Keltikangas Järvinen, Liisa ^a   Räikkönen, Katri ^a   Hautanen, Aarno ^a   Adlercreutz, Herman ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

ACTH; cortisol; insulin resistance; vital exhaustion

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; HYDROCORTISONE; HYPOPHYSIS HORMONE; INSULIN;

ADULT; ANGER; ARTICLE; ATHEROSCLEROSIS; BORDERLINE HYPERTENSION; CONTROLLED STUDY; CORONARY RISK; EMOTIONAL STRESS; EXHAUSTION; HOSTILITY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS ADRENAL SYSTEM; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; PARANOIA; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RISK FACTOR; TYPE A BEHAVIOR;

EID: 0030041964     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.2.275     Document Type: Article

References (47)

1. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipid- emia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-194.
2. Björntorp P. Hypothesis: visceral fat accumulation: the missing link between psychosocial factors, and cardiovascular disease. J Int Med. 1991;230:195-201.
3. Björntorp P. Metabolic implications of body fat distribution. Diabetes Care. 1991;14:1132-1143.
4. Juhan-Vague I, Alessi MC. Plasminogen activator inhibitor 1 and atherothrombosis. Thromb Haemost. 1993;70:138-143.
5. Glass AR, Burman WT, Dahms WT, Bohem TH. Endocrine function in human obesity. Metabolism. 1980;30:89-104.
6. Yung R. Endocrinological aspects in obesity. J Clin Endocrinol Metab. 1984;13:597-612.
7. Migeon CJ, Green OC, Eckert JP. Study of adrenocorticoid function in obesity. J Clin Endocrinol Metab. 1963;12:718-739.
8. Dunkelman SS, Fairburst B, Plager J. Cortisol metabolism in obesity. J Clin Endocrinol Metab. 1964;24:832-841.
9. Pasquali R, Cantobelli S, Casimirri F, Capelli M, Bortoluzzi L, Flamia R, Labate AMM, Barbara L. The hypothalamico-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab. 1993;77:341-346.
10. Mårin P, Darin N, Amemiya T, Andersson B, Jern S, Björntorp P. Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism. 1992;8:882-886.
11. Vague J. Obesities. London, England: Libbey; 1991.
12. Krantz DS, Glass DC, Snyder ML. Helplessness, stress level, and the coronary prone behavior pattern. J Exper Soc Psychol. 1974;41:467-475.
13. Williams RB. Biological mechanisms mediating the relationship between behavior and coronary heart disease. In: Siegman AW, Dembroski TM, eds. In Search of Coronary-Prone Behavior: Beyond Type A. Hillsdale, NJ: Lawrence Erlbaum Associates, Inc; 1989:195-205.
14. Appels A, Mulder P. Fatigue and heart disease: the association between vital exhaustion and past, present and future coronary heart disease. J Psychosom Res. 1989;33:727-738.
15. Suarez EC, Williams RB, Kuhn CM. Biobehavioral basis of coronary prone behavior in middle-aged men, part II: serum cholesterol, the type A behavior pattern, and hostility as interactive modulators of physiological reactivity. Psychosom Med. 1991;53:528-537.
16. Williams RB, Lane JD, Kuhn CM. Type A behavior and elevated physiological and neuroendocrine responses to cognitive tasks. Science. 1982;218:483-485.
17. Pope MK, Smith TW. Cortisol excretion in high and low cynically hostile men. Psychosom Med, 1991;53:386-392.
18. Frankenhaeuser M, Lundberg U, Forsman L. Dissociation between sympathetic-adrenal and pituitary adrenal responses to an achievement situation characterized by high controllability: comparison between type A and type B males and females. Biol Psychol. 1980;10:79-91.
19. Lambert W, MacEvoy B, Klackenberg-Larsson I. The relation of stress hormone excretion to type A behavior and to health. J Hum Stress. 1987;13:128-135.
20. Julius S, Gudbrandsson T. Early association of sympathetic overactivity, hypertension, insulin resistance and coronary risk. J Cardiovasc Pharmacol. 1992;20:540-548.
21. Jenkins CD, Zyzanski SJ, Rosenman RH. Jenkins Activity Survey, Form C: Instructions for Hand Scoring. New York, NY: Psychological Corp; 1979.
22. Williams RB, Barefoot JC, Shekelle RB. The health consequences of hostility. In: Chesney MA, Rosenman RH, eds. Anger and Hostility in Cardiovascular and Behavioral Disorders. Washington, DC: Hemisphere; 1985:173-185.
23. Comrey AL. A factor analysis of items on the MMPI hypomania scale. Educ Psychol Meas. 1958;18:312-322.
24. Lazare A, Klerman GL, Armor DJ. Oral, obsessive and hysterical personality patterns: replication of factor analysis in an independent sample. J Psychiatr Res. 1970;7:275-279.
25. Derogatis LR. SCL-90 Manual I. Revised ed. Baltimore, Md: Johns Hopkins University Press; 1977.
26. Appels A. Loss of control, vital exhaustion and coronary heart disease. In: Steptoe A, Appels A, eds. Stress, Personal Control and Health. Brussels, Belgium: John Wiley & Sons Ltd; 1989:215-235.
27. Spielberger CD, Johnson EH, Russell SF. The experience and expression of anger: construction and validation of an anger expression scale. In: Chesney MA, Rosenman RH, eds. Anger and Hostility in Cardiovascular and Behavioral Disorders. Washington, DC: Hemisphere; 1985:5-30.
28. Reunanen A, Hanses O, Maatela J, Impivaara O, Aromaa A, Type A behaviour pattern in Finland. Ann Clin Res. 1987;19:114-119.
29. Julkunen J, Salonen R, Kaplan GA, Chesney MA, Salonen JT. Hostility and progression of carotid atherosclerosis. Psychosom Med. 1994;56:519-525.
30. Finley PR, Schifman RB, Williams RJ. Cholesterol in high-density lipoprotein: use of Mg (2+)/dextran sulphate in enzymic measurement. Clin Chem. 1972;18:499-502.
31. Kluft C, Verheijen JH. Leiden fibrinolysis working party: blood collection and handling procedures for assessment of tissue-type plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1). Fibrinolysis. 1990;4(suppl 2):155-161.
32. Tabachnick BG, Fidell LS. Using Multivariate Statistics. 2nd ed. New York, NY: Harper & Row; 1989.
33. Pfiffner D, Bättig K. Type A behavior and its relations to psychophysiological reactivity: a review. Arch Nerv Super. 1989;31:183-208.
34. Feinleib M, Simon A, Gillum R. Prodromal symptoms and signs of sudden death. Circulation. 1975;51:155-159.
35. Stowers M, Short D. Warning symptoms before myocardial infarction. Br Heart J. 1970;32:833-838.
36. Appels A, Höppener P, Mulder P. A questionnaire to assess premonitory symptoms of myocardial infarction. Int J Cardiol. 1987;17:15-24.
37. Falger PRJ, Schouten EGW. Exhaustion, psychological stressors in the work environment, and acute myocardial infarction in adult men. J Psychosom Res. 1992;36:777-786.
38. Appels A, Falger PR, Schouten EGW. Vital exhaustion as a risk indicator for myocardial infarction in women. J Psychosom Res. 1993;37:881-890.
39. Kop W, Appels A, De Leon C. Vital exhaustion predicts new cardiac events after successful coronary angioplasty. Psychosom Med. 1994;56:281-288.
40. Mills PJ, Schneider RH, Dimsdale JE. Anger assessment and reactivity to stress. J Psychosom Res. 1989;33:379-382.
41. Lazarus RS, Folkman S. Stress, Appraisal and Coping. New York, NY: Springer-Verlag; 1984.
42. Miller WB, Rosenfeld R. A psychophysiological study of denial following acute myocardial infarction. J Psychosom Res. 1975;19:42-54.
43. Henry JP, Stephens PM. Stress, Health, and the Social Environment: A Sociobiological Approach to Medicine. New York, NY: Springer-Verlag; 1977.
44. Folkow B. Physiology of behavior and BP regulation in animals. In: Julius S, Basser DR, eds. Handbook of Hypertension: Behavioral Factors in Hypertension. Amsterdam, Netherlands: Elsevier; 1987:1-18.
45. Kissebah AH, Peirish AN. Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus. Diabetes Metab Rev. 1989;5:83-109.
46. Demitrack MA, Dale JK, Straus SE. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab. 1991;73:1224-1234.
47. Hautanen A, Adlercreutz H. Altered adrenocorticotropin and cortisol secretion in abdominal obesity: implication for the insulin resistance syndrome. J Clin Intern Med. 1993;234:461-469.